Bacterial infections present a serious challenge to healthcare practitioners due to the emergence of resistance to numerous conventional antibacterial drugs. Therefore, new bacterial targets and new antimicrobials are unmet medical needs. Rhodanine derivatives are known to possess potent antimicrobial activities. In this study, we determined the activity spectrum of a series of new rhodanine derivatives against representative Gram-positive and Gram-negative bacterial strains. Compounds 3a and 5a had the highest activity with minimum inhibitory concentrations in the range of 1.12 - 2.5 μg/mL. Transmission electron microscope results confirmed that activities against bacteria occurred via rupturing of the cell wall. Molecular modeling results suggested that rhodanine derivatives have the potential to irreversibly bind to the penicillin-binding protein (PBP) Ser62 residue in the active site. Thus, our results suggested that these rhodanine derivatives could be potential antibacterial drug candidates with strong activity against Gram-negative bacteria.
References
[1]
Chopra, I., et al. (2008) Treatment of Health-Care-Associated Infections Caused by Gram-Negative Bacteria: A Consensus Statement. The Lancet Infectious Diseases, 8, 133-139. https://doi.org/10.1016/S1473-3099(08)70018-5
[2]
Overbye, K.M. and Barrett, J.F. (2005) Antibiotics: Where Did We Go Wrong? Drug Discovery Today, 10, 45-52. https://doi.org/10.1016/S1359-6446(04)03285-4
[3]
Rossolini, G.M.A., Pecile, P. and Pollini, S. (2014) Update on the Antibiotic Resistance Crisis. Current Opinion in Pharmacology, 18, 56-60. https://doi.org/10.1016/j.coph.2014.09.006
[4]
Moellering, R.C. (2008) Current Treatment Options for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases, 46, 1032-1037. https://doi.org/10.1086/529445
[5]
Liu, J.C., et al. (2014) Synthesis and Evaluation of the Antimicrobial Activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one Derivatives. European Journal of Medicinal Chemistry, 74, 405-410. https://doi.org/10.1016/j.ejmech.2013.12.054
[6]
Schemmel, K.E., Padiyara, R.S. and D’Souza, J.J. (2010) Aldose Reductase Inhibitors in the Treatment of Diabetic Peripheral Neuropathy: A Review. Journal of Diabetes and Its Complications, 24, 354-360. https://doi.org/10.1016/j.jdiacomp.2009.07.005
[7]
Cutshall, N.S., O’Day, C. and Prezhdo, M. (2005) Rhodanine Derivatives as Inhibitors of JSP-1. Bioorganic & Medicinal Chemistry Letters, 15, 3374-3379. https://doi.org/10.1016/j.bmcl.2005.05.034
Azizmohammadi, M., et al. (2013) 2H-chromene Derivatives Bearing Thiazolidine-2,4-dione, Rhodanine or Hydantoin Moieties as Potential Anticancer Agents. European Journal of Medicinal Chemistry, 59, 15-22. https://doi.org/10.1016/j.ejmech.2012.10.044
Kumar, G., et al. (2007) Discovery of a Rhodanine Class of Compounds as Inhibitors of Plasmodium falciparum Enoyl-Acyl Carrier Protein Reductase. Journal of Medicinal Chemistry, 50, 2665-2675. https://doi.org/10.1021/jm061257w
[12]
Ergenc, N., et al. (1999) Synthesis and Hypnotic Activity of New 4-Thiazolidinone and 2-thioxo-4,5-imidazolidinedione Derivatives. Archiv der Pharmazie (Weinheim), 332, 343-347. https://doi.org/10.1002/(SICI)1521-4184(199910)332:10<343::AID-ARDP343>3.0.CO;2-0
[13]
Rauter, A.P., et al. (2005) Bioactive Pseudo-C-Nucleosides Containing Thiazole, Thiazolidinone, and Tetrazole Rings. Journal of Carbohydrate Chemistry, 24, 275-296. https://doi.org/10.1081/CAR-200060396
[14]
Gollapalli Naga Raju, K.B.S., et al. (2015) Synthesis, Characterization and Antimicrobial Evaluation of Some Azole Derivatives. World Journal of Pharmacy and Pharmaceutical Sciences, 4, 865-875.
[15]
Sjostrand, F.S. (1956) A Method to Improve Contrast in High Resolution Electron Microscopy of Ultrathin Tissue Sections. Experimental Cell Research, 10, 657-664. https://doi.org/10.1016/0014-4827(56)90043-X
[16]
Reynolds, E.S. (1963) The Use of Lead Citrate at High pH as an Electron-Opaque Stain in electron Microscopy. Journal of Cell Biology, 17, 208-212. https://doi.org/10.1083/jcb.17.1.208
[17]
Karnovsky, M.J. (1965) A Formaldehyde-Glutaraldehyde Fixative of High Osmolarity for Use in Electron Microscopy. Journal of Cell Biology, 27, 137.
[18]
Protein Data Bank. http://www.pdb.org
[19]
Kishida, H., Roper, D.I., Lloyd, A., Park, S.-Y. and Tame, J.R.H. (2006) Crystal Structure of Penicillin Binding Protein 4 (dacB) from Escherichia coli, Both in the Native Form and Covalently Linked to Various Antibiotics. Biochemistry, 45, 783-792. https://doi.org/10.1021/bi051533t
Schrödinger Release 2015-2: Schrödinger Suite 2015-2 Protein Preparation Wizard; Epik Version 3.2, S., LLC, New York, NY, 2015; Impact Version 6.7, Schrödinger, LLC, New York, NY, 2015; Prime Version 4.0, Schrödinger, LLC, New York, NY, 2015.
[22]
Madhavi Sastry, G.A., Day, T., Annabhimoju, R. and Sherman, W. (2013) Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments. Journal of Computer-Aided Molecular Design, 27, 221-234. https://doi.org/10.1007/s10822-013-9644-8
[23]
Maestro 9.9.013, S., LLC: 101 SW Main Street, Suite 1300, Portland, OR, USA. http://www.schrodinger.com
[24]
Schrödinger Release 2015-2: LigPrep, v., Schrödinger, LLC, New York, NY, 2015.
[25]
Zhu, K.B., Greenwood, J.R., Day, T., Abel, R., Farid, R.S. and Harder, E. (2014) Docking Covalent Inhibitors: A Parameter Free Approach to Pose Prediction and Scoring. Journal of Chemical Information and Modeling, 54, 1932-1940. https://doi.org/10.1021/ci500118s
[26]
Small-Molecule Drug Discovery Suite 2015-2: Glide, v., Schrödinger, LLC, New York, NY, 2015.
[27]
Halgren, T.A.M., Friesner, R.A., Beard, H.S., Frye, L.L., Pollard, W.T. and Banks, J.L. (2004) Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. Journal of Medicinal Chemistry, 47, 1750-1759. https://doi.org/10.1021/jm030644s
[28]
Pardasani, R.T., Sherry, D., Chaturvedi, V., et al. (2001) Synthetic and Antibacterial Studies of Rhodanine Derivatives with Indol-2,3-diones. Indian Journal of Chemistry, 40, 1275-1278.
[29]
Grant, E.B., et al. (2000) The Synthesis and SAR of Rhodanines as Novel Class C Beta-Lactamase Inhibitors. Bioorganic & Medicinal Chemistry Letters, 10, 2179-2182. https://doi.org/10.1016/S0960-894X(00)00444-3
[30]
Tejchman, W., et al. (2017) Antibacterial Properties of 5-Substituted Derivatives of Rhodanine-3-Carboxyalkyl Acids. Medicinal Chemistry Research, 26, 1316-1324. https://doi.org/10.1007/s00044-017-1852-7
[31]
Tomasic, T. and Peterlin Masic, L. (2012) Rhodanine as a Scaffold in Drug Discovery: A Critical Review of Its Biological Activities and Mechanisms of Target Modulation. Expert Opinion on Drug Discovery, 7, 549-560. https://doi.org/10.1517/17460441.2012.688743
[32]
Metwally, N.H. (2014) A Simple Green Synthesis of (Z)-5-arylmethylene-4-thioxo-thiazolidines and Thiopyrano[2,3-d]thiazolidine-2-thiones in PEG-400 under Catalyst-Free Conditions. Journal of Sulfur Chemistry, 35, 528-537. https://doi.org/10.1080/17415993.2014.933341
[33]
Sing, W.T.L., Yeo, S.L., Lim, S.P., Sim, M.M., et al. (2001) Arylalkylidene Rhodanine with Bulky and Hydrophobic Functional Group as Selective HCV NS3 Protease Inhibitor. Bioorganic & Medicinal Chemistry Letters, 11, 91-94. https://doi.org/10.1016/S0960-894X(00)00610-7
[34]
Khodair, A.I. (2000) A Convenient Synthesis of 2-arylidene-5H-thiazolo[2,3-b]qui-nazoline-3,5[2H]-diones and Their Benzoquinazoline Derivatives. Journal of Heterocyclic Chemistry, 39, 1153-1160. https://doi.org/10.1002/jhet.5570390607
[35]
Ohishi, Y.M., Nagahara, M., Yajima, M., Kajikawa, N., Miahara, K., Takano, T., et al. (1990) Preparations of 5-alkylmethylidene-3-carboxymethylrhodanine Derivatives and Their Aldose Reductase Inhibitory Activity. Chemical and Pharmaceutical Bulletin, 39, 1911-1919. https://doi.org/10.1248/cpb.38.1911
